Oratecan Shows Promise in Phase I Clinical Trial for Colon Cancer
Hanmi Pharmaceuticals and Kinex Pharmaceuticals recently announced preliminary findings from a Phase I clinical trial of Oratecan, an oral formulation of irinotecan (Camptosar), an already-approved intravenous treatment for colon cancer. The oral ... Read more